Pharmaceutical composition for transdermal delivery

Details Pharmaceutical composition for transdermal delivery Pharmaceutical composition for transdermal delivery

1994-04-28

1996-12-03

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

514784, 514785, 514786, 514946, 514947, 514969, A61K 970, A61F 1300, A61L 1510

Patent

active

055805744

ABSTRACT:
A pharmaceutical composition for transdermal delivery comprising an effective amount of an active ingredient selected from a benzodiazepine and a benzodiazepine antagonist; isopropanol; propylene glycol; oleic acid; and water. Additionally, the composition may contain diacetin, Cetiol B.RTM., caprylic acid, Silicon fluid, Miglyol.RTM. 840 or transcutol.

REFERENCES:
patent: 4537776 (1985-08-01), Cooper I
patent: 4557934 (1985-12-01), Cooper II
patent: 4626539 (1986-12-01), Aungst et al.
patent: 4719239 (1988-01-01), Muller et al.
patent: 4722941 (1988-02-01), Eckert et al.
patent: 4789547 (1988-12-01), Song et al.
patent: 4837025 (1989-06-01), Guillemet et al.
patent: 4863970 (1989-09-01), Patel et al.
patent: 4879297 (1989-11-01), Mahjour et al.
patent: 4885174 (1989-12-01), Bodor et al.
patent: 4959365 (1990-09-01), Francoeur et al.
patent: 5023085 (1991-06-01), Francoeur et al.
patent: 5069909 (1991-12-01), Sharma et al.
patent: 5096715 (1992-03-01), Sinclair
patent: 5176916 (1993-01-01), Yamanaka et al.
patent: 5196410 (1993-03-01), Francoeur et al.
patent: 5212199 (1993-05-01), Heiber et al.
patent: 5230897 (1993-07-01), Griffin et al.
patent: 5234957 (1993-08-01), Mantelle I
patent: 5238933 (1993-08-01), Catz et al.
patent: 5296222 (1994-03-01), Petersen et al.
patent: 5318960 (1994-06-01), Toppo
patent: 5332576 (1994-07-01), Mantelle II
patent: 5352457 (1994-10-01), Jenkins
patent: 5362497 (1994-11-01), Yamada et al.
patent: 5374645 (1994-12-01), Kurihara-Bergstrom et al.
patent: 5378473 (1995-01-01), Sharma et al.
Ogiso, et al., Percutaneous Absorption of Clonazepam in Rabbit, Chem. Pharm. Bull. 37(2), pp. 442-445 (1989).
Ogiso, et al. Membrane-Controlled Transdermal Therapeutic System Containing Clonazepam and Anticonvulsant Activity After Its Application, Chem. Pharm. Bull. 37(2) pp. 446-449 (1989).
Kumar, et al., In Vitro Transdermal Delivery of .sup.14 C-Clonazepam Across Hairless Guinea Pig, Pharmaceutical Research, vol. 8, No. 10, Oct. 1991 (Supplement p. S-205).

Affiliated with

Also associated with

Rating

Pharmaceutical composition for transdermal delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for transdermal delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for transdermal delivery will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-783379